Physician profile
Michael P Shea
NPI 1679677819
$384.62
in general payments reported to CMS, 2019-2025
11 companies · $171 in 2025
The $171 reported for 2025 was more than what a typical Sports Medicine (Family Medicine) provider received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $92.49 · 2020: $16.10 · 2023: $53.45 · 2024: $51.97 · 2025: $171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $276.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $276.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $95.08 | 2025 | Clottriever Bold Catheter |
| Vertex Pharmaceuticals Incorporated | $48.81 | 2025 | |
| Pacira Therapeutics, INC. | $46.31 | 2019-2020 | |
| Inari Medical, INC. | $42.68 | 2024-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Bioventus LLC | $41.11 | 2019-2024 | Exogen Ultrasound Bone Healing System |
| Endo Pharmaceuticals INC. | $24.23 | 2019 | |
| Heron Therapeutics, INC. | $23.43 | 2023 | Zynrelef |
| Abbott Laboratories | $20.33 | 2024 | Penta |
| Pacira Pharmaceuticals Incorporated | $15.01 | 2023 | Exparel, Iovera, Zilretta |
| Novo Nordisk INC | $15.01 | 2023 | Rybelsus, Ozempic |
| Mallinckrodt Enterprises LLC | $12.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Shea listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.